Characteristics of sickle cell patients with frequent emergency department visits and hospitalizations., 2021 Journal Article, Academic Journal
Characteristics and potential biomarkers of adult sickle cell patients with chronic pain., 2020 Journal Article, Academic Journal
Two new γ chain variants: Hb F-Augusta GA [(G)γ59(E3)Lys → Arg; HBG2: c.179A > G] and Hb F-Port Royal-II [(A)γ125(H3)Glu → Ala; HBG1: c.377A > C]., 2014 Journal Article, Academic Journal
Professional Service
Georgia State Contract, Services for Sickle Cell Anemia Patients, Newborn Screening confirmation program
2006 - Present
Role: Program Coordinator
Primary Coordinator: TCD With Transfusions Changing to Hydroxyurea (TWiTCH)
2011 - 2016
Lab Coordinator: CLBH589BUS43T: Phase I Study to Determine the Safety and Tolerability of Escalating Doses of Panobinostat (LBH589) in Patients with Sickle Cell Disease
2009 - 2016
Lab Coordinator: CC-4047-SCD-001 Trial, A Prospective, Multi-center, Open-Label, Dose-Escalation Study to determine the maximum tolerated dose, safety and effect of induction of fetal hemoglobin of CC-4047 in subjects with Sickle Cell Disease, Celgene Corporation
2008 - 2015
Lab Coordinator: Mu Opioid Polymorphisms as Genetic Modifiers of Pain and Opioid Use In SCD
2009 - 2014
